Open- | Close- |
Vol / Avg.0 / 88.027K | Mkt Cap42.869M |
Day Range- - - | 52 Wk Range0.540 - 1.930 |
Quince Therapeutics Stock (NASDAQ: QNCX) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 88.027K | Mkt Cap42.869M |
Day Range- - - | 52 Wk Range0.540 - 1.930 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
QNCX | Quince Therapeutics | 1.01% | 42.9M |
HOOK | HOOKIPA Pharma | 0% | 49.1M |
FBIO | Fortress Biotech | -1.53% | 38.1M |
ESLA | Estrella Immunopharma | -5.22% | 44.7M |
GANX | Gain Therapeutics | -3.4% | 36M |
You can purchase shares of Quince Therapeutics (NASDAQ: QNCX) through any online brokerage.
Other companies in Quince Therapeutics’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA), Gain Therapeutics (NASDAQ:GANX) and Intensity Therapeutics (NASDAQ:INTS).
There is no analysis for Quince Therapeutics
The stock price for Quince Therapeutics (NASDAQ: QNCX) is $1 last updated December 4, 2023 at 9:23 PM UTC.
There is no dividend information for Quince Therapeutics.
Quince Therapeutics’s Q3 earnings are confirmed for Tuesday, November 14, 2023.
There is no upcoming split for Quince Therapeutics.
Quince Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.